Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
In the last 90 days, Bicycle Therapeutics PLC insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
Superinvestors holding BCYC, Q2 2026
No superinvestor reported holding BCYC in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of BCYC each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2024
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office
Q3 2024
1 superinvestor holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2024
2 superinvestors holding at quarter end
Q1 2024
1 superinvestor holding at quarter end